REALE, Marcella
 Distribuzione geografica
Continente #
NA - Nord America 13.354
AS - Asia 8.750
EU - Europa 8.104
Continente sconosciuto - Info sul continente non disponibili 1.162
SA - Sud America 1.020
AF - Africa 131
OC - Oceania 8
Totale 32.529
Nazione #
US - Stati Uniti d'America 12.999
SG - Singapore 3.296
CN - Cina 2.720
IE - Irlanda 1.233
UA - Ucraina 1.181
IT - Italia 1.169
SE - Svezia 941
TR - Turchia 924
RU - Federazione Russa 867
BR - Brasile 839
GB - Regno Unito 835
VN - Vietnam 788
DE - Germania 610
FR - Francia 526
IN - India 415
FI - Finlandia 297
CA - Canada 203
BD - Bangladesh 136
HK - Hong Kong 121
AR - Argentina 74
CZ - Repubblica Ceca 73
MX - Messico 70
AT - Austria 65
PL - Polonia 62
ES - Italia 48
KR - Corea 48
NL - Olanda 48
JP - Giappone 46
BE - Belgio 43
ZA - Sudafrica 41
IQ - Iraq 38
EC - Ecuador 28
ID - Indonesia 28
JM - Giamaica 22
PK - Pakistan 21
CL - Cile 20
LT - Lituania 20
CO - Colombia 19
EU - Europa 19
MA - Marocco 19
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 16
EG - Egitto 14
UZ - Uzbekistan 14
CH - Svizzera 13
HN - Honduras 13
KE - Kenya 13
RO - Romania 13
VE - Venezuela 12
CR - Costa Rica 11
IL - Israele 11
IR - Iran 11
MY - Malesia 10
PH - Filippine 9
PY - Paraguay 9
TN - Tunisia 9
DZ - Algeria 8
TH - Thailandia 8
AZ - Azerbaigian 7
BG - Bulgaria 7
HR - Croazia 7
LB - Libano 7
NP - Nepal 7
AL - Albania 6
GT - Guatemala 6
JO - Giordania 6
KZ - Kazakistan 6
RS - Serbia 6
AM - Armenia 5
AU - Australia 5
BO - Bolivia 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GR - Grecia 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BY - Bielorussia 4
DK - Danimarca 4
GE - Georgia 4
NI - Nicaragua 4
PA - Panama 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
BN - Brunei Darussalam 3
CM - Camerun 3
HU - Ungheria 3
NO - Norvegia 3
SR - Suriname 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
BZ - Belize 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 31.352
Città #
Singapore 2.415
San Jose 1.710
Chandler 1.402
Jacksonville 1.340
Dublin 1.226
Ashburn 810
Dallas 660
Beijing 607
Council Bluffs 603
Princeton 511
Southend 505
Izmir 466
Shenzhen 450
Nanjing 390
Los Angeles 318
Santa Clara 293
Ho Chi Minh City 276
The Dalles 274
Wilmington 266
Dearborn 258
Chieti 239
Cambridge 222
New York 207
Ann Arbor 193
Hanoi 170
Munich 161
Altamura 158
Buffalo 157
Nanchang 140
Tongling 138
Boardman 135
Woodbridge 124
Hong Kong 104
São Paulo 104
Pescara 88
Moscow 80
Shenyang 76
Redondo Beach 67
Washington 65
Hebei 60
Tianjin 60
Grevenbroich 57
Brooklyn 56
Houston 56
Montreal 55
Jiaxing 54
Rome 52
Columbus 50
Kunming 50
Turku 50
Chennai 48
Vienna 48
Denver 46
Warsaw 45
Orem 44
Tokyo 44
Toronto 44
Helsinki 41
Atlanta 39
Montréal 39
Brussels 38
Dong Ket 38
Milan 38
Brno 37
Hefei 37
Jinan 37
Hangzhou 36
Norwalk 36
Da Nang 35
Frankfurt am Main 34
Olomouc 33
Phoenix 33
Amsterdam 32
Chicago 32
London 32
Seoul 32
Haiphong 31
Changsha 30
Seattle 30
Falls Church 27
San Francisco 27
Johannesburg 26
Poplar 26
Stockholm 24
Mexico City 23
Guangzhou 22
Manchester 22
Mcallen 22
Ningbo 22
Zhengzhou 22
Boston 21
Rio de Janeiro 20
Augusta 19
Brasília 19
Pune 19
Ankara 18
Orange 18
San Mateo 18
Auburn Hills 17
Belo Horizonte 16
Totale 19.545
Nome #
Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegeneration 575
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 256
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 203
Effects of 50 Hz sinusoidal electromagnetic fields on MCP-1 and RANTES generated from activated human macrophages 193
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation 193
Cholinergic Markers and Cytokines in OSA Patients 193
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 191
Antiinflammatory effects in THP-1 cells treated with verbascoside 187
Blood natural killer activity is reduced in men with occupational stress and job insecurity working in a university 185
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 182
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 179
Interleukin-6 and mast cells 179
Activity of matrix metallo proteinases (MMPs) and the tissue inhibitorof MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. 177
Follow up study on the immune response to low frequency electromagnetic fields in men and women working in a museum. 170
Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production 170
Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients 169
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges 169
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 169
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 168
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 166
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 165
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 163
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 162
NSAID Coniugates for the treatment of Alzheimer's Disease 159
"In vitro" effects of different arsenic compounds on PBMC (preliminary study). 158
Cholinergic System Dysfunction in Multiple Sclerosis Patients 158
Critical review on the presence of phthalates in food and evidence of their biological impact 158
Anti-inflammatory properties of acetylcholinesterase inhibitors administred in Alzheimer's disease 157
Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines 157
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. 157
Effect of occupational stress and anxiety on natural killer lymphocyte activity of men and women employed in a university. 156
Age-related Expression of Cholinergic Markers and Cytokines in the Olfactory Bulb of a Rat Model of Alzheimer’s Disease. 156
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 156
Epidermal Growth Factor Immunotherapy: Exploring the Effects of NB-UVB Exposure 156
Work stress and innate immune response 153
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 151
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 151
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 150
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect? 149
Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: present and future applications 149
The immune response of women with prolonged exposure to electromagnetic fields produced by radiotelevision broadcasting stations. 148
EMF Exposure Facilitates Wound Healing Events Modulating Cytokines Expression. 148
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 147
In vitro effects of vanadate on human immune functions 146
Well-being at work and immune response 146
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 145
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 145
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 144
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 141
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 141
MicroRNA in Sjögren's syndrome: Their potential roles in pathogenesis and diagnosis 141
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 140
Alzheimer's Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies 140
Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease 140
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 139
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 138
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 138
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 137
In vitro effects of nickel-sulphate on immune functions of normal and nickel-allergic subjects: a regulatory role for zinc. 137
A pathophysiological role for selective alteration of the cytokine-chemokine network - inflammatory theory in Alzheimer's disease 136
Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway 136
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology 136
Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women 136
Cytokine Levels and UVr Sensitivity in HaCaT Cells and Cetuximab Treated Patients. 135
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 134
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 134
Profiling of canonical and non-traditional cytokine levels in IFNbeta-treated RR-MS patients 134
Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions 134
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 134
Very low electromagnetic field and innate immunity in HaCaT cells 132
Job strain in different types of employment affects the immune response 132
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 132
Heat shock protein 70: implication for Alzheimer's disease 131
Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase 131
Inhibitory effects of cadmium on peripheral blood mononuclear cell proliferation and cytokine release are reversed by zinc and selenium salts 131
Network between cytokines, cortisol and occupational stress in gas and oilfield workers 131
Production of cytokines in trichinellosis infected mice 130
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 130
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 130
Th17 cytokines from pathogenesis to therapeutic strategies in chronic plaque psoriasis 130
Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease 129
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 129
Extremely Low Frequency Electromagnetic Field and Cytokines Production. 129
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 128
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 127
Cytokines and T cells in atopic dermatitis. 127
Mitochondria as an easy target to oxidative stress events in Parkinson's disease 127
Circulating Adipokine Levels in Mild Psoriatic Patients 127
SERUM HMW ADIPONECTIN, RBP-4, VISFATIN, APELIN AND HMGB1 LEVELS IN MILD PSORIATIC PATIENTS 127
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 127
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 126
The association between chemokine receptor gene polymorphisms and two neurodegenerative disorders: alzheimer and parkinsons disease. 126
Effect of environmental extremely low-frequency electromagnetic fields exposure on inflammatory mediators and serotonin metabolism in a human neuroblastoma cell line. 126
Anti-inflammatory strategy: Old ally or new promise in therapy 126
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 125
Evaluation of Salivary Cytokines and Vitamin D Levels in Periodontopathic Patients 125
In vitro effects of low frequency electromagnetic fields on Anti Microbial Peptides (AMP) expression 125
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 125
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 124
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 124
Totale 15.214
Categoria #
all - tutte 128.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.114 0 14 14 222 72 32 43 93 88 34 134 368
2022/20233.810 296 454 220 447 379 771 227 300 487 63 96 70
2023/20242.282 104 68 582 60 110 518 477 62 18 31 29 223
2024/20254.794 319 855 802 96 131 167 131 233 485 220 585 770
2025/202610.051 801 472 1.107 1.168 915 566 1.572 673 1.005 795 709 268
2026/2027798 189 609 0 0 0 0 0 0 0 0 0 0
Totale 32.529